CNC vs HUM
Centene Corp. and Humana Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | CNC | HUM |
|---|---|---|
| Revenue | $194.8B | $129.7B |
| Net income | $-6.7B | $1.2B |
| Gross margin | 7.3% | — |
| Net margin | −3.4% | 0.9% |
| Return on equity | −28.8% | 7.0% |
| Diluted EPS | −$13.53 | $9.84 |
| Dividend / share | — | $3.54 |
| Payout ratio | — | 36.2% |
| Free cash flow | $4.3B | $375.0M |
| Equity | $20.0B | $17.7B |
| Net debt / equity | −0.02× | 0.46× |
| Current ratio | 1.10× | 2.00× |
| Revenue CAGR 5y | 11.9% | 10.9% |
| Profit CAGR 5y | — | −18.8% |
CNC bills 1.5× the revenue of HUM, and CNC closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
10 years side by side
| Fiscal year | CNC | HUM |
|---|---|---|
| FY2025 | $194.8B | $129.7B |
| FY2024 | $163.1B | $117.8B |
| FY2023 | $154.0B | $106.4B |
| FY2022 | $144.5B | $92.9B |
| FY2021 | $126.0B | $83.1B |
| FY2020 | $111.1B | $77.2B |
| FY2019 | $74.6B | $64.9B |
| FY2018 | $60.1B | $56.9B |
| FY2017 | $48.4B | $53.8B |
| FY2016 | $40.6B | $54.4B |
Net income by year
Bottom line
| Fiscal year | CNC | HUM |
|---|---|---|
| FY2025 | $-6.7B | $1.2B |
| FY2024 | $3.3B | $1.2B |
| FY2023 | $2.7B | $2.5B |
| FY2022 | $1.2B | $2.8B |
| FY2021 | $1.3B | $2.9B |
| FY2020 | $1.8B | $3.4B |
| FY2019 | $1.3B | $2.7B |
| FY2018 | $900.0M | $1.7B |
| FY2017 | $828.0M | $2.4B |
| FY2016 | $562.0M | $614.0M |